Active Pharmaceutical Ingredient (Generic)

COLFOSCERIL PALMITATE

🩺 LUNG SURFACTANTS 💊 1 Marketed Brands
Clinical Profile:

*Prophylaxis & treatment of neonatal respiratory distress syndrome (RDS):* BY ENDOTRACHEAL TUBE: 5 ml/ kg as soon as the diagnosis of RDS or risk of RDS is established; the second and third dose should be administered 12 and 24 hrs later to those infants remaining on ventilators.

Marketed Brands Containing COLFOSCERIL PALMITATE (1) Compare Brand Prices
Brand Name Manufacturer / Company Available Pack Sizes & Price Action
EXOSURF NEONATAL Lung surfactant 🏢 GSK
Inj 1: Rs.26906.88
View Details →